PETV vs. BTCY, MBOT, NXGL, SSKN, PSTV, NURO, GCTK, OSA, VAPO, and VVOS
Should you be buying PetVivo stock or one of its competitors? The main competitors of PetVivo include Biotricity (BTCY), Microbot Medical (MBOT), NEXGEL (NXGL), STRATA Skin Sciences (SSKN), Plus Therapeutics (PSTV), NeuroMetrix (NURO), GlucoTrack (GCTK), ProSomnus (OSA), Vapotherm (VAPO), and Vivos Therapeutics (VVOS). These companies are all part of the "surgical & medical instruments" industry.
PetVivo (NASDAQ:PETV) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, community ranking, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment.
In the previous week, Biotricity had 1 more articles in the media than PetVivo. MarketBeat recorded 1 mentions for Biotricity and 0 mentions for PetVivo. PetVivo's average media sentiment score of 0.00 equaled Biotricity'saverage media sentiment score.
PetVivo has higher earnings, but lower revenue than Biotricity. PetVivo is trading at a lower price-to-earnings ratio than Biotricity, indicating that it is currently the more affordable of the two stocks.
PetVivo has a beta of 2.15, suggesting that its share price is 115% more volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.54, suggesting that its share price is 54% more volatile than the S&P 500.
Biotricity has a net margin of -125.43% compared to PetVivo's net margin of -1,016.64%. Biotricity's return on equity of 0.00% beat PetVivo's return on equity.
24.6% of PetVivo shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 20.1% of PetVivo shares are held by company insiders. Comparatively, 20.5% of Biotricity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
PetVivo and Biotricity both received 0 outperform votes by MarketBeat users.
Summary
Biotricity beats PetVivo on 7 of the 12 factors compared between the two stocks.
Get PetVivo News Delivered to You Automatically
Sign up to receive the latest news and ratings for PETV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
